ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 159 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2021. The put-call ratio across all filers is 3.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,655,174 | +8.0% | 59,008 | +129.6% | 0.01% | +16.7% |
| Q4 2019 | $1,532,000 | -20.8% | 25,700 | -51.3% | 0.01% | -20.0% |
| Q3 2019 | $1,935,000 | -0.1% | 52,763 | +26.7% | 0.02% | +7.1% |
| Q2 2019 | $1,937,000 | +4.9% | 41,651 | +0.1% | 0.01% | +16.7% |
| Q3 2018 | $1,846,000 | +276.7% | 41,600 | +232.8% | 0.01% | +300.0% |
| Q2 2018 | $490,000 | -97.5% | 12,500 | -94.9% | 0.00% | -97.1% |
| Q2 2015 | $19,851,000 | +219.0% | 242,800 | +261.3% | 0.10% | +194.3% |
| Q1 2015 | $6,223,000 | +312.7% | 67,200 | +80.2% | 0.04% | +288.9% |
| Q4 2014 | $1,508,000 | – | 37,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
| Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
| Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
| Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
| Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
| Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
| Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
| WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
| Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |